Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Current Deferred Revenue: 2013-2022

Historic Current Deferred Revenue for Nutex Health (NUTX) over the last 9 years, with Q1 2022 value amounting to $92111.0.

  • Nutex Health's Current Deferred Revenue rose 7109.24% to $92111.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $92111.0, marking a year-over-year increase of 7109.24%. This contributed to the annual value of $173919.0 for FY2021, which is 12679.07% up from last year.
  • Per Nutex Health's latest filing, its Current Deferred Revenue stood at $92111.0 for Q1 2022, which was up 7109.24% from $173919.0 recorded in Q4 2021.
  • In the past 5 years, Nutex Health's Current Deferred Revenue registered a high of $173919.0 during Q4 2021, and its lowest value of $600.0 during Q3 2019.
  • For the 5-year period, Nutex Health's Current Deferred Revenue averaged around $52588.6, with its median value being $40217.0 (2020).
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first tumbled by 8560.12% in 2019, then soared by 274366.67% in 2020.
  • Nutex Health's Current Deferred Revenue (Quarter) stood at $4167.0 in 2018, then skyrocketed by 3873.12% to $165560.0 in 2019, then tumbled by 53.68% to $76687.0 in 2020, then surged by 126.79% to $173919.0 in 2021, then plummeted by 47.04% to $92111.0 in 2022.
  • Its Current Deferred Revenue was $92111.0 in Q1 2022, compared to $173919.0 in Q4 2021 and $45022.0 in Q3 2021.